ONTRUZANT® (trastuzumab-dttb) Logo

Before prescribing ONTRUZANT, please read the accompanying
Prescribing Information, including the Boxed Warning about cardiomyopathy,
infusion reactions (pulmonary toxicity), and embryo-fetal toxicity.


THE MERCK CO-PAY ASSISTANCE PROGRAM

The Merck Co-pay Assistance Program offers assistance to eligible patients who need help affording ONTRUZANT.

  • Once enrolled, eligible, privately insured patients pay the first $5 of their co-pay per infusion
  • Maximum co-pay assistance program benefit is $25,000 per patient, per calendar year

Co-pay assistance from the Merck Co-pay Assistance Program is not insurance. Restrictions apply. See Terms and Conditions.

Co-pay assistance may be available for patients who

  • Are a resident of the United States
  • Have private health insurance that provides coverage for ONTRUZANT under a medical benefit program
  • Have been prescribed ONTRUZANT for an FDA-approved indication
  • Meet all other Terms and Conditions of the program

The Merck Co-pay Assistance Program is not valid for patients covered under a Government Program, as that term is defined in the Terms and Conditions. The Merck Co-pay Assistance Program is not valid for uninsured patients.

Patient and health care professional must submit all required information. Please see the enrollment form for details.

Other financial support options

What if my patient isn't eligible for the Merck Co-pay Assistance Program?

Your patient may be able to get help from an independent co-pay assistance foundation. A representative can provide you with information about independent foundations that may be able to provide financial support to patients who do not qualify for the Merck Co-pay Assistance Program. Each independent foundation has its own eligibility criteria and application process.



 WELCOME TO

THE MERCK ACCESS PROGRAM

ARE YOU A US HEALTH CARE PROFESSIONAL?

Please choose